Sanara MedTech
SMTI
65 hedge funds and large institutions have $25.6M invested in Sanara MedTech in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 5 closing their positions.
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
108% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 13
23% more funds holding
Funds holding: 53 → 65 (+12)
5.45% less ownership
Funds ownership: 21.74% → 16.28% (-5.5%)
43% less capital invested
Capital invested by funds: $45.2M → $25.6M (-$19.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$822K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$569K |
| 3 |
Renaissance Technologies
New York
|
+$557K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$543K |
| 5 |
Squarepoint
New York
|
+$507K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$15.2M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$307K |
| 3 |
Charles Schwab
San Francisco,
California
|
-$215K |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$198K |
| 5 |
Morgan Stanley
New York
|
-$177K |
SMTI Hedge Fund Activity: Q1 2026 in Review
65 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q1 2026, worth a combined $25.6M — down 43% from $45.2M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new SMTI positions and 5 closed out — a net gain of 13 holders — while 27 added to existing stakes and 13 trimmed.
The largest buyer was AQR Capital Management, opening a new position worth an estimated $822K. The largest seller was Baird Financial Group, cutting an estimated $15.2M.
- 65 institutional investors held Sanara MedTech (SMTI) as of Q1 2026, up from 53 in Q4 2025.
- Funds reported $25.6M of Sanara MedTech stock for Q1 2026, down 43% quarter-over-quarter.
- 18 funds opened new Sanara MedTech positions in Q1 2026 and 5 closed out, a net change of +13 holders.
- The largest Sanara MedTech buyer in Q1 2026 was AQR Capital Management, an estimated $822K added.
- The largest Sanara MedTech seller in Q1 2026 was Baird Financial Group, an estimated $15.2M sold.
Based on aggregated 13F filings for Q1 2026.